SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015316
Filing Date
2019-05-02
Accepted
2019-05-02 16:01:19
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20190331.htm 10-Q 1374471
2 EX-31.1 cbio-ex311_7.htm EX-31.1 13589
3 EX-31.2 cbio-ex312_8.htm EX-31.2 13676
4 EX-32.1 cbio-ex321_6.htm EX-32.1 9720
5 EX-32.2 cbio-ex322_9.htm EX-32.2 9468
6 GRAPHIC g2olrf2vr3lt000001.jpg GRAPHIC 18842
  Complete submission text file 0001564590-19-015316.txt   5118976

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbio-20190331.xml EX-101.INS 1123897
8 XBRL TAXONOMY EXTENSION SCHEMA cbio-20190331.xsd EX-101.SCH 41807
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20190331_cal.xml EX-101.CAL 39984
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20190331_def.xml EX-101.DEF 101805
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20190331_lab.xml EX-101.LAB 314694
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20190331_pre.xml EX-101.PRE 230837
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 19791805
SIC: 2834 Pharmaceutical Preparations